Cimeio Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cimeio Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on gene editing, cellular therapies, and immunotherapy. It is developing a portfolio of treatments that combine engineered cells with immune therapies, aiming to preserve cell function while resisting depletion by paired immunotherapies. The approach seeks to address serious and life-threatening conditions, including genetic diseases, hematologic malignancies, and severe autoimmune disorders. 

As a small to mid-sized organization, it advances its work by identifying protein variants that can be edited into cells to maintain activity under immunotherapy pressure. In December 2024, Cimeio announced a research collaboration with Kyowa Kirin to develop novel therapies for diseases with high unmet need.

Sign up for free to view info

Company overview Email format